Yuanhe Holdings Portfolio Companies Achieve Major Milestones Across Innovation, Product Launches, and Accolades

At the beginning of the New Year, good news keeps coming. The companies invested in by the various investment teams of Yuanhe Holdings have all made new progress. Let's take a look!

CRYSTAL Pharmatech's Global Headquarters R&D Building in Suzhou Industrial Park has been fully commissioned, officially entering a new phase of rapid development. As the landmark building of the headquarters base, the CRYSTAL Pharmatech building integrates efficient and advanced office and R&D functions. Among these, the R&D laboratory area exceeds 10,927 square meters, with office space covering approximately 16,428 square meters, designed to create a comfortable and open working environment that fosters teamwork and creative exchange. With the official launch of the headquarters base, CRYSTAL Pharmatech will fully leverage its global layout advantages to provide professional, efficient, and sustainable R&D and production services for pharmaceutical companies worldwide.

The List of Key Special Projects for Disruptive Technology Innovation under the National Key R&D Program has been announced. "Leukemia-Targeted Cell Therapy Technology," led by HemaCell, has been successfully selected, with Dr. Fangfang Zhu, founder of HemaCell, serving as the project’s chief scientist. The project has successfully secured funding support thanks to its urgent market demand, innovative outcomes, and broad application prospects.

The State-owned Assets Supervision and Administration Commission of the State Council announced the list of winners for the 4th Central Enterprises Innovation Competition, with Catug's participating project "Plasmid DNA and mRNA R&D and Production Quality Control Technology Platform" being awarded the competition's Excellence Award. This project is also one of only three outstanding gene engineering projects in this year’s competition.

At the 6th "Carbon Exploration" Entrepreneurs' New Year Sharing Conference and the 12th "Solar Energy Cup" PV Industry Awards Ceremony in 2024, StarLore Intelligence won the "Most Influential PV Operation and Maintenance Enterprise" award at the Solar Energy Cup for its deep application of drone new energy operation and maintenance systems in the photovoltaic field.

At the Kunpeng Application Innovation Competition 2024 National Finals in China, Boyun Technology won the gold award in the Enterprise Competition - Basic Software track and the bronze award in the Enterprise Competition - Financial track with its outstanding technical strength and innovative solutions.

With its outstanding performance in RNAi therapy and cardiovascular, immunological, and metabolic diseases, SANEGENEBIO has been listed on the "2024 Hurun Global Gazelles" and "2024 CYZONE Future Unicorn 100" lists.

Chuanglan Biotech's Self-Developed "Respiratory Pathogen Nucleic Acid Detection Kit (PCR Fluorescence Probe Method)" Officially Receives NMPA Class III Medical Device Registration Approval

Return to List